Business-card sized cardiac care
for the 21st century.

Documents and helps diagnose
heart conditions outside of the
consulting room.

Results can be shared at any
time and can be evaluated by a

Less clinician-patient
meetings are needed for
effective treatment.


  • ECG irregularities
  • Arrhythmia
  • Increased stroke risk (based on atrial fibrillation)
  • Increased sudden cardiac arrest risk (based on ventricular heterogeneity a condition for tachycardia)
  • Oxygen deficiency


  • Winning patients for self-assessment and cooperation
  • Support for a healthy lifestyle
  • Measurement results are stored on the smart device forming a health journal
  • Results can be shared in PDF format


  • Making the number of patient-clinician meetings reasonable
  • Assessment during symptoms to support diagnosis
  • Recording can be taken without the presence of a clinician
  • High accuracy recording

Recommended by specialists

"I recommend it not only for my patients living with a heart disease but for my health-conscious patients too"

"We were the first one to test WIWE on patients living with heart diseases and also on patients with no previous record. Its algorithm draws our attention to the possibility of a problem without further medical examination"

Prof. Dr. Béla Merkely

Director of SOTE Heart Center
Vice President of the European Cardiology Society

"What I love about WIWE is that I can use it even if my smartphone is not on me, or if I don't know how to use a smartphone because the results can be synced later"

Dr. Bertalan Meskó

Medical Futurist

"I've been so impressed with WIWE that we decided that we're going to roll out a pilot-project amongst a sample population of patients we want to monitor. I'm absolutely confident that WIWE's going to make a tremendous difference in the quality of care we offer our patients while at the same time reducing the cost of doing that"

Prof. Rubin Pillay

Head of Healthcare Innovation
Faculty at University of Alabama, USA

A WIWE Mobil ECG can support your work the following ways

ECG wave analysis

  • Evaluation of ECG parameters (PQ, QRS, QTc)
  • Examination of atrial and ventricular activation
  • Information on possible conduction abnormalities
  • Pre-screening of patients

Arrhythmia detection

  • Detection of frequent ectopic beats
  • Evaluation of heart rate fluctuation
  • AF detection: stroke risk factor

Patient monitoring

  • Measurement reports can be shared with a clinician
  • ECG parameters, Risk levels
  • Entire ECG recording can be shared
  • Remote diagnostics

Sudden cardiac arrest

  • Tendency assessment
  • Evaluation of ventricular heterogeneity
  • Evaluation of the bioelectrical stability of the heart
  • Ventricular fibrillation/ tachycardia risk assessment


ECG assessment using a unique, intelligent algorithm: parameters are based on the recorded lead I. wave's average majority cícle (QRS, QTc, PQ). Highly advanced mobile ECG technology that facilitates the reliable examination of the low-amplitude P wave.

Arrhythmia / Atrial fibrillation

Based on the recorded cardiac cycles, the application compiles a so called Poincaré-plot, which serves to indicate the heart rate fluctuation. In the figure, the closer the displayed points are located to one another, the more regular the heart rate is. A significant fluctuation in the cardiac rhythm (highly scattered distribution of the points) indicates cardiac arrhythmia (atrial fibrillation is a severe type of arrhythmias).

Prerequisite of ventricular

Increased heterogeneity (electrical instability) of ventricular cardiac cells increases the probability of malignant arrhythmias (ventricular tachycardia, ventricular fibrillation), which may lead to sudden cardiac arrest.

Ventricular heterogeneity shows the discrepancy in the bioelectric characteristics of the cardiac cells constituting the ventricular myocardium. This discrepancy may also be present under healthy conditions in a deterministic form (quasi-rigid connection between the cells). In case of pathological condition the heterogeneity may be enhanced and the harmonized functioning of cardiomyocytes tends to get worse, which means that a random fluctuation and significant instability in the bioelectric phenomena can be detected. This kind of instability will increase the risk of malignant ventricular arrhythmia, and thus the risk of sudden cardiac arrest.

On the graph you can see the evaluation of the Ventricular Heterogeneity which gets calculated based on two parameter: the average ventricular heterogeneity and the deviation of the ventricular heterogeneity. The different colored zones represent the areas in which the results can be classified into.

In a world-unique way risk assessment of the malignant ventricular arrhythmia (tachycardia/fibrillation) is based on the QRST intgral.

Mobile ECG - Clinical-grade results!

  • Two electrode ECG with the accuracy of lead I. of the clinical ECG device and it also has clinical testing background (study)
  • CE approved mobile ECG and algorithm to detect atrial fibrillation instantly
  • CE approved algorithm that evaluates ECG with 98.69% accuracy

Check-up with the push of a button:

  • ECG recordings and evaluation between patient visits
  • Monitoring several parameters with one device (ECG, blood oxygen level, heart rate, physical activity)
  • Recording various conditions

Closer cooperation higher quality care

  • Patients can record clinical-grade ECG anytime, anywhere
  • Outstanding cooperation and satisfaction compared to the traditional method
  • Your patients have a deeper understanding of the treatment and they feel more inspired to cooperate with you

Smart application smart decisions

  • Easy-to-use application for easy workflow
  • Trends are easy to follow from the patient's health journal
  • Automatic risk assessment
  • Results can be printed and cataloged from PDF

Possibility for cloud integration

  • Real-time monitoring and risk assessment
  • Monitoring anytime, anywhere
  • Monitor tendencies
  • Patient results are accessible anytime, anywhere